Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

1964
2025

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1967 1
1971 1
1993 1
1996 1
1999 1
2000 2
2001 2
2003 3
2004 2
2005 5
2006 3
2007 6
2008 4
2009 7
2010 4
2011 3
2012 4
2013 7
2014 9
2015 12
2016 6
2017 4
2018 6
2019 8
2020 7
2021 10
2022 11
2023 6
2024 10
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

125 results

Results by year

Filters applied: . Clear all
Page 1
Lipodystrophy Syndromes.
Hussain I, Garg A. Hussain I, et al. Endocrinol Metab Clin North Am. 2016 Dec;45(4):783-797. doi: 10.1016/j.ecl.2016.06.012. Epub 2016 Oct 6. Endocrinol Metab Clin North Am. 2016. PMID: 27823605 Free PMC article. Review.
The two most common genetic varieties include congenital generalized lipodystrophy and familial partial lipodystrophy; the two most common acquired varieties include acquired generalized lipodystrophy and acquired partial lipodystrophy
The two most common genetic varieties include congenital generalized lipodystrophy and familial partial lipodystroph
The Diagnosis and Management of Lipodystrophy Syndromes: A Multi-Society Practice Guideline.
Brown RJ, Araujo-Vilar D, Cheung PT, Dunger D, Garg A, Jack M, Mungai L, Oral EA, Patni N, Rother KI, von Schnurbein J, Sorkina E, Stanley T, Vigouroux C, Wabitsch M, Williams R, Yorifuji T. Brown RJ, et al. J Clin Endocrinol Metab. 2016 Dec;101(12):4500-4511. doi: 10.1210/jc.2016-2466. Epub 2016 Oct 6. J Clin Endocrinol Metab. 2016. PMID: 27710244 Free PMC article. Review.
Patients with most lipodystrophy syndromes should be screened for diabetes, dyslipidemia, and liver, kidney, and heart disease annually. Diet is essential for the management of metabolic complications of lipodystrophy. Metreleptin therapy is effective for metabolic …
Patients with most lipodystrophy syndromes should be screened for diabetes, dyslipidemia, and liver, kidney, and heart disease annual …
Lipodystrophy for the Diabetologist-What to Look For.
Patni N, Garg A. Patni N, et al. Curr Diab Rep. 2022 Sep;22(9):461-470. doi: 10.1007/s11892-022-01485-w. Epub 2022 Jul 11. Curr Diab Rep. 2022. PMID: 35821558 Free PMC article. Review.
In this review, we discuss the various subtypes and when to suspect and how to diagnose lipodystrophy. RECENT FINDINGS: The four major subtypes are autosomal recessive, congenital generalized lipodystrophy (CGL); acquired generalized lipodyst
In this review, we discuss the various subtypes and when to suspect and how to diagnose lipodystrophy. RECENT FINDINGS: The four majo …
Diagnosis and treatment of lipodystrophy: a step-by-step approach.
Araújo-Vilar D, Santini F. Araújo-Vilar D, et al. J Endocrinol Invest. 2019 Jan;42(1):61-73. doi: 10.1007/s40618-018-0887-z. Epub 2018 Apr 27. J Endocrinol Invest. 2019. PMID: 29704234 Free PMC article. Review.
RESULTS: Lipodystrophy is classified as genetic or acquired and by the distribution of fat loss, which can be generalized or partial. ...Leptin replacement therapy (metreleptin) has been found to improve metabolic parameters in many patients with lipodystrophy
RESULTS: Lipodystrophy is classified as genetic or acquired and by the distribution of fat loss, which can be generalized or p …
Generalized lipoatrophy syndromes.
Sorkina E, Chichkova V. Sorkina E, et al. Presse Med. 2021 Nov;50(3):104075. doi: 10.1016/j.lpm.2021.104075. Epub 2021 Sep 22. Presse Med. 2021. PMID: 34562560 Review.
Generalized lipodystrophy (GL) syndromes are a group of rare heterogenous disorders, characterized by total subcutaneous fat loss. ...In this review we aimed to summarize the information on all forms of generalized lipodystrophy, especially the ones of
Generalized lipodystrophy (GL) syndromes are a group of rare heterogenous disorders, characterized by total subcutaneous fat l
Lipodystrophies in Children.
Mainieri F, Chiarelli F. Mainieri F, et al. Horm Res Paediatr. 2022;95(4):305-320. doi: 10.1159/000522620. Epub 2022 Feb 21. Horm Res Paediatr. 2022. PMID: 35189617 Free article. Review.
BACKGROUND: Lipodystrophy includes a wide group of diseases characterized by reduction, absence, or altered distribution of adipose tissue. Lipodystrophies are classified into generalized or partial, according to the fat distribution, and congenital or acquir …
BACKGROUND: Lipodystrophy includes a wide group of diseases characterized by reduction, absence, or altered distribution of adipose t …
Lipodystrophies.
Garg A. Garg A. Am J Med. 2000 Feb;108(2):143-52. doi: 10.1016/s0002-9343(99)00414-3. Am J Med. 2000. PMID: 11126308 Review.
The main subtypes of familial lipodystrophies are congenital generalized lipodystrophy, an autosomal recessive disorder characterized by near complete lack of metabolically active adipose tissue from birth, and familial partial lipodystrophy, Dunnigan …
The main subtypes of familial lipodystrophies are congenital generalized lipodystrophy, an autosomal recessive disorder …
Generalized lipodystrophy.
Seip M. Seip M. Ergeb Inn Med Kinderheilkd. 1971;31:59-95. doi: 10.1007/978-3-642-65213-4_2. Ergeb Inn Med Kinderheilkd. 1971. PMID: 4933543 Review. No abstract available.
Partial lipodystrophy: Clinical presentation and treatment.
Mosbah H, Vatier C, Vigouroux C. Mosbah H, et al. Ann Endocrinol (Paris). 2024 Jun;85(3):197-200. doi: 10.1016/j.ando.2024.05.015. Epub 2024 Jun 12. Ann Endocrinol (Paris). 2024. PMID: 38871513 Review.
Lipodystrophic syndromes are acquired or genetic rare diseases, characterized by a generalized or partial lack of adipose tissue leading to metabolic alterations linked to strong insulin resistance. ...When standard treatments have failed to control metabolic disorders, th …
Lipodystrophic syndromes are acquired or genetic rare diseases, characterized by a generalized or partial lack of adipose tissue lead …
Nuclear envelope-related lipodystrophies.
Guénantin AC, Briand N, Bidault G, Afonso P, Béréziat V, Vatier C, Lascols O, Caron-Debarle M, Capeau J, Vigouroux C. Guénantin AC, et al. Semin Cell Dev Biol. 2014 May;29:148-57. doi: 10.1016/j.semcdb.2013.12.015. Epub 2013 Dec 30. Semin Cell Dev Biol. 2014. PMID: 24384368 Review.
Lipodystrophic syndromes are rare and heterogeneous diseases, either genetic or acquired, characterized by generalized or partial fat atrophy associated with metabolic complications comprising insulin-resistant diabetes, dyslipidemia, and non-alcoholic fatty liver disease. …
Lipodystrophic syndromes are rare and heterogeneous diseases, either genetic or acquired, characterized by generalized or partial fat …
125 results